Stakeholders’ Acceptability of Pharmacist-Led Screening in Community Pharmacies: A Systematic Review-Reference-Cited by-同舟云学术

Stakeholders’ Acceptability of Pharmacist-Led Screening in Community Pharmacies: A Systematic Review

Published:2022-10 Issue:4 Volume:63 Page:636-646
ISSN:0749-3797
Container-title:American Journal of Preventive Medicine
language:en
Short-container-title:American Journal of Preventive Medicine

Author:

El-Den Sarira^ORCID,Lee Yee Lam Elim,Gide Duha N.,O'Reilly Claire L.^ORCID

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Epidemiology

Reference75 articles.

1. Better decision making in preventive health screening: balancing benefits and harms;Bell;Can Fam Physician,2017

2. Pharmacists as accessible primary health care providers: review of the evidence;Tsuyuki;Can Pharm J (Ott),2018

3. Community pharmacy. Australian Industry and Skills Committee. https://nationalindustryinsights.aisc.net.au/industries/retail-and-wholesale/community-pharmacy. Updated January 24, 2022. Accessed September 2, 2021.

4. Evaluation of frequency of encounters with primary care physicians vs visits to community pharmacies among Medicare beneficiaries;Berenbrok;JAMA Netw Open,2020

5. Primary health care in Australia. Australian Institute of Health and Welfare. https://www.aihw.gov.au/reports/primary-health-care/primary-health-care-in-australia/contents/about-primary-health-care. Updated May 24, 2016. Accessed March 14, 2022.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacist-led biometric screenings: A retrospective chart review in a community pharmacy;Research in Social and Administrative Pharmacy;2024-02

2. Perinatal depression screening in community pharmacy: Exploring pharmacists’ roles, training and resource needs using content analysis;International Journal of Clinical Pharmacy;2023-10

3. Evaluation of a training program to support the implementation of a community pharmacist-led support service for people living with severe and persistent mental illness;Journal of the American Pharmacists Association;2023-05

4. Community pharmacists’ acceptability of pharmacist-delivered depression screening for older adults: a qualitative study;International Journal of Clinical Pharmacy;2023-04-20

5. Feasibility of Community Pharmacist-Initiated and Point-of-Care CYP2C19 Genotype-Guided De-Escalation of Oral P2Y12 Inhibitors;Genes;2023-02-25